The “Cystatin C Testing Market: Opportunity Analysis and Future Assessment 2022-2030” research report offers a comprehensive and an in-depth evaluation of the progressive market trends, growth areas, opportunities, drivers, and restraints, which would allow clients and stakeholders to line up their market strategies as stated in present & future market dynamics. A strategic assessment of the market growth trajectory in the forecast period, whilst taking into account the Covid-19 impact on the industry, is also included in the research study, with certain information established by research experts.
Global Cystatin C Testing Market, By Component Type (Cartridges, Detection, Buffer tubes, ID chip), By Sample Type (Serum, Plasma, Heparin, EDTA), By Type (Colorimetric Assay Based Tests, Enzymatic Tests, ELISA Based Tests, Others), By End-User (Hospitals, Clinics, Diagnostic Centres), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, & Africa) is expected to grow at a significant CAGR for the period between 2022 and 2030.The Cystatin C testing market is expected to grow at a significant growth rate in the upcoming years.
Cystatin C testing is paving the way by using new approaches to diagnose and treat people. Cystatin have been extensively used for analysis of renal functions and glomerular filtration rate (GFR) that is the measurement of serum creatinine and creatinine clearance rate for keeping a check on the functioning of kidneys. This has been extremely useful in clinical medicine regardless of the complexities related to its quantification and interpretation. Attributing to its sensitivity and specificity for kidney function as both innate and transplanted kidneys, the cystatin C is considered to have an enormous potential as a promising marker at it incorporates the capability to carry out a quick and accurate analysis of renal functions which is majorly expected to drive the cystatin C testing market in the forthcoming future.
In addition to that, Cystatin C testing market is expected to grow at a rapid pace in the near future owing to the rising prevalence of various disorders among the population such as myocardial infarction, muscular dystrophy and kidney related disorders. For instance, according to National Kidney Organization, in U.S. approximately 80 Mn individuals are at a risk of kidney disorder out of which its more common in women (14%) than in men (12%). Thus, kidney disease is one the major factor which is projected to foster the growth of the global cystatin C testing market over the years. Moreover, the increasing number of hospitals, research laboratories, diagnostic centers and academic labs is propelling the growth of the global cystatin C testing market globally. Furthermore, the cost effectiveness of the reagents and awareness of health-related disorders is estimated to boost the growth of the global cystatin C testing market over the forecast period.
However, the stringent product-based regulations are considerably one of the primary factors which is estimated to hamper the market growth in the near future. At the same time, the demand of cystatin C is increasing rapidly with the global prevalence of chronic kidney diseases that is 13.4% globally which is estimated to offer lucrative opportunities to the market growth in the coming years.
Reports and Insights Study identifies some of the key participating players in the Cystatin C Testing Market globally are Abbott, Thermo Fisher, Siemens Healthcare, Eurolyser Diagnostica, Randox Laboratories, DiaSys Diagnostic Systems, Diazyme Laboratories, Tosoh India, BBI Solutions, PerkinElmer, among others.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth includes (but not restricted to):
New product designs and launches
Current product compliance
Concerns for use of Cystatin C Testing
Advantages of Cystatin C Testing
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to take informed decision.